Article
Potential weight-loss drug meets goals in mid-stage trial as race accelerates
Rating:
0.0
Views:
75
Likes:
1
Library:
1
Denmark's Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment achieved up to 14.9% weight loss in a mid-stage trial, lining up a potential contestant in the booming obesity drug market.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value